Open tender · Germany · Pharmaceutical products
Open house Arzneimittelrabattverträge Nilotinib, ATC L01EA03 (ausgeschlossen Nilotinib dispergiert in Apfelmus, es sei denn, der Hersteller genießt hierfür Patentschutz)
In EnglishOpen-house drug discount contracts for Nilotinib, ATC L01EA03 (excluded Nilotinib dispersed in applesauce, unless the manufacturer has patent protection for this)
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open-house drug discount contracts for Nilotinib, ATC L01EA03 (excluded Nilotinib dispersed in applesauce, unless the manufacturer has patent…”. Bids close on 5 January 2027, 12:00 CET. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Abschluss nicht-exklusiver Rabattvereinbarungen über den Wirkstoff Nilotinib (ATC L01EA03) nach § 130a Abs. 8 SGB V.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 0 requirements to qualify and the 3 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences